Industry

DUBLIN–(BUSINESS WIRE)–The “U.S. Assisted Living Facility Market Size, Share & Trends Analysis Report by Age (More Than 85, 75-84, 65-74, Less Than 65), Region (West, South, Midwest), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. assisted living facility market size is expected to reach USD 140.8 billion by 2030 and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Pruritus Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Pruritus pipeline products, Pruritus epidemiology, Pruritus market valuations and forecast, Pruritus drugs sales and competitive landscape in the US. The research is classified into seven sections – Pruritus treatment options, pipeline products, … [Read more…]

Strategic Investment Expected to Help Accelerate Cardiac Monitoring and Strategic Relationship Aims to Create Improved Disease State Treatment Models SAN JOSE, Calif.–(BUSINESS WIRE)–#vitalconnect–VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of an investment funded by Health Insight Capital, the investment arm of HCA Healthcare Inc., (NYSE: HCA), one … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Aicardi Goutieres Syndrome – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Aicardi-Goutieres Syndrome (AGS) – Epidemiology Forecast – 2032’ report delivers an in-depth understanding of the historical and forecasted epidemiology of Aicardi-Goutieres Syndrome (AGS) in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering. This Ventricular Tachycardia (V-tach or VT) – Pipeline Insight, 2022″ report provides comprehensive insights about 5+ companies and 7+ pipeline drugs in Ventricular Tachycardia (V-tach or VT) pipeline landscape. It covers the pipeline drug profiles, including … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Generalized Myasthenia Gravis (gMG) – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This ‘Generalized Myasthenia Gravis (gMG)- Epidemiology Forecast – 2032’ report delivers an in-depth understanding of Generalized Myasthenia Gravis (gMG) historical and forecasted epidemiology in the United States, EU-5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

– The Sik-Kee Au TCM Brain Theory® Assessment for ADHD and ASD (“SKATBT-A3”), which measures the effectiveness of the treatment on the patient’s overall body and neurodevelopmental conditions, showed a mean percentage improvement of 37% in the second efficacy trial based on the scoring system of SKATBT-A3. – The first efficacy trial using personalized TCM … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, today announced the publication of new research on pediatric mental health in a brief titled, “The Kids Are Not Alright: Pediatric Mental Health Care Utilization from 2016 – 2021.” The research was conducted by the Clarify Health Institute, which is led by … [Read more…]

Clinical Expertise and Advanced Therapies Cater to Growing Patient Population Statewide COLUMBUS, Ohio & CLEVELAND–(BUSINESS WIRE)–#VirtisHealthAmbulatoryInfusionCenters—Virtis Health, an innovative, national provider dedicated to therapeutic and diagnostic services for patients with complex conditions requiring specialty infusible and injectable medications, announced today the unveiling of ambulatory infusion centers (AIC) in Columbus and Cleveland, Ohio. Virtis Health is … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the publication of preclinical data showing the effect of sodium phenylbutyrate (PB) and taurursodiol (TURSO, also known as ursodoxicoltaurine) on the transcriptomic and metabolomic profiles of primary skin fibroblasts from adults with sporadic amyotrophic lateral sclerosis (ALS) and adults without ALS. These … [Read more…]